Prognostic significance of ductal carcinoma in situ coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes
Molecular and Clinical Oncology · 27.10.2025 · 24 (1) · 1-8
DOI: 10.3892/mco.2025.2910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Clinical Oncology, online erschienen am 27.10.2025. Verfasst von Neslihan Koray Fedai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara 06230, Turkey. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Biological differences exist between invasive ductal carcinoma (IDC) and IDC + ductal carcinoma in situ (DCIS) tumors including variations in tumor grade, hormone receptor status, human epidermal growth factor receptor 2 (HER2) expression, proliferative activity and molecular subtype. The present study evaluated the impact of the coexistence of IDC + DCIS on tumor microenvironment, tumor-infiltrating lymphocytes (TILs), clinical and pathological features, prognosis and survival. A total of 165 patients with IDC and 404 with IDC + DCIS were enrolled and treated in the outpatient clinic, Hacettepe University Department of Medical Oncology (Ankara, Turkey) between January 2014 and July 2021. Compared with IDC, patients with IDC + DCIS were more likely to be hormone receptor-positive and had a lower rate of mastectomy and Ki-67 index (both P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Hacettepe University, School of Medicine, Ankara 06230, Turkey.
- Department of Medical Oncology, Hacettepe University, School of Medicine, Ankara 06230, Turkey.
- Department of Pathology, Hacettepe University, School of Medicine, Ankara 06230, Turkey.
Zitieren
APA
Fedai, N. K., Koc, I., Kavgaci, G., Uner, M., Uner, A., Aksoy, S., & Kertmen, N. (2025). Prognostic significance of ductal carcinoma in situ coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes. Molecular and Clinical Oncology, 24(1), 1-8. https://doi.org/10.3892/mco.2025.2910
Vancouver
Fedai NK, Koc I, Kavgaci G, Uner M, Uner A, Aksoy S, et al. Prognostic significance of ductal carcinoma in situ coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes. Molecular and Clinical Oncology. 2025;24(1):1-8. doi:10.3892/mco.2025.2910
BibTeX
@article{Fedai2025,
author = {Fedai, Neslihan Koray and Koc, Ilgin and Kavgaci, Gozde and Uner, Meral and Uner, Aysegul and Aksoy, Sercan and Kertmen, Neyran},
title = {Prognostic significance of ductal carcinoma in situ coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes},
journal = {Molecular and Clinical Oncology},
year = {2025},
volume = {24},
number = {1},
pages = {1--8},
doi = {10.3892/mco.2025.2910}
}
EUVIMED